This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
ARRB2 / Beta-arrestin-2 · Western blot design guide
Design a Western Blot for ARRB2
Source-linked ARRB2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-ARRB2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
ARRB2 Western Blot Experimental Design Guide
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | ~46.1 kDa | |
| Observed band | 46 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
Important caveats
Reasons your observed band may differ from the expected size.
| PTM | Phosphorylated + Ubl conjugation | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 5 isoform(s) |
Section 1
Source-Linked ARRB2 Western Blot Protocol Options
The PA1845 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HELA at 40ug, Rat Skeletal Muscle at 50ug (catalog PA1845) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | PA1845; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
Section 2
What Is the Expected ARRB2 Western Blot Band Size?
ARRB2 is predicted at 46.1 kDa and observed at 46 kDa; the cause of the small difference is not established.
| Band at 46 kDa | Matches the empirical ARRB2 band and is close to the 46.1 kDa predicted mass. |
| Single band near 46 kDa | Consistent with ARRB2; the five isoforms are not known here to resolve separately. |
| Additional band above 46 kDa | Could represent an ARRB2 isoform, but its identity and migration are unestablished. |
| Additional band below 46 kDa | Could represent an ARRB2 isoform, but its identity and migration are unestablished. |
💡Expected ARRB2 appearanceARRB2 has a predicted mass of 46.1 kDa and an empirical band at 46 kDa; use an independent antibody or ARRB2 depletion to verify band identity.
| Predicted ARRB2 mass | 46.1 kDa predicted; the observed band is 46 kDa. |
| Splice isoform 1 | Its individual mass and migration are not supplied. |
| Splice isoform 2 | Its size relative to the other isoforms is not supplied. |
| Splice isoform 3 | Its size relative to the other isoforms is not supplied. |
| Splice isoform 4 | Its size relative to the other isoforms is not supplied. |
| Splice isoform 5 | Its size relative to the other isoforms is not supplied. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | ARRB2 can occupy cytoplasmic, nuclear, membrane, and vesicle compartments. | Check a validated positive lysate and the relevant cellular fractions. |
| Band higher than expected | An isoform is possible, but no isoform migration is supplied. | Compare with the 46 kDa reference band and verify identity by ARRB2 depletion. |
| Band lower than expected | An isoform is possible, but no isoform migration is supplied. | Verify identity with an independent ARRB2 antibody or ARRB2 depletion. |
| Multiple bands | Five splice isoforms are listed, but distinct bands are unproven. | Check isoform coverage of the antibody and test band identity by ARRB2 depletion. |
| Weak or no signal | ARRB2 translocates to the plasma membrane and may be depleted from the sampled fraction. | Check membrane and cytoplasmic fractions alongside a validated positive lysate. |
Experiment evidence
Western blot images showing ARRB2 band
PA1845 · ARRB2
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for ARRB2 Western blot
🧪For positive controls for ARRB2 in Western blot, you can use an HPA-confirmed positive sample once expression data are available.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: HPA provides no tissue expression data here, so tissue controls cannot be validated; use siRNA knockdown or a KO line for a negative control.
HPA tissue expression evidence for ARRB2
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Higher expression tissues · candidate positive controls from IHC
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
Lower expression tissues · IHC evidence, not confirmed WB-negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Section 3
Advanced ARRB2 Western Blot Tips
Deeper troubleshooting and optimisation questions for ARRB2, answered from its protein features.
How should ARRB2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could ARRB2 isoforms produce different bands?
Isoforms · Five isoforms are listed. Isoforms 3 and 5 lack canonical residues 39–53; isoform 4 replaces residue 119 with a longer sequence; isoforms 2 and 3 replace residue 360 with a longer sequence. These changes could affect apparent size, but the features do not establish where each isoform migrates.
Which phosphorylation sites matter when choosing an ARRB2 antibody?
PTM · UniProt lists phosphotyrosine 48, phosphoserine 360, and phosphothreonine 382 in canonical coordinates. Isoforms 3 and 5 lack the segment containing Tyr48; isoforms 2 and 3 replace Ser360. Check the antibody’s target sequence and numbering convention before interpreting a site-specific signal.
Can GPCR stimulation change where ARRB2 is detected?
Induction · ARRB2 is listed in the cytoplasm, nucleus, membrane, and cytoplasmic vesicles. UniProt notes translocation to the plasma membrane and colocalization with antagonist-stimulated GPCRs. Compare matched fractions or whole-cell samples when assessing changes in signal; a compartment shift can affect a fraction’s band intensity.
How should transfer be checked for ARRB2?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the PA1845 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should ARRB2 bands be quantified across fractions?
Quantitation · Quantify comparable sample fractions consistently and identify whether the measurement represents total ARRB2 or one compartment. ARRB2 has several listed locations and can translocate to the plasma membrane, so a change in one fraction’s signal does not alone establish a change in total abundance.
Should ARRB2 migrate above its predicted mass?
Interpretation · The supplied apparent band is 46 kDa, close to the predicted 46.1 kDa. Listed modifications and splice variants do not, by themselves, establish a visible shift or explain a different apparent mass.
UniProt lists hydroxyproline at canonical positions 176 and 181, both by PHD2. If assessing these modifications, use a reagent that distinguishes hydroxylated ARRB2; the listed sites alone do not predict a separate band.
First compare them with the supplied 46 kDa band and consider the documented splice changes. ARRB2 is also listed as a homooligomer and as associating with ARRB1, but those interactions do not establish the identity of an extra band. Confirm its identity with a suitable ARRB2-specific reagent or orthogonal assay.
UniProt lists hydroxyproline at canonical positions 176 and 181, both by PHD2. If assessing these modifications, use a reagent that distinguishes hydroxylated ARRB2; the listed sites alone do not predict a separate band.
First compare them with the supplied 46 kDa band and consider the documented splice changes. ARRB2 is also listed as a homooligomer and as associating with ARRB1, but those interactions do not establish the identity of an extra band. Confirm its identity with a suitable ARRB2-specific reagent or orthogonal assay.
Boster reagents
ARRB2 Western Blot Antibodies
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Real WB data
Anti-Beta Arrestin 2/ARRB2 Antibody Picoband®
Cat # PA1845
The catalog reports one anti-ARRB2 antibody, PA1845, with stated Human, Mouse, and Rat reactivity. Its WB image shows HeLa whole-cell and rat skeletal muscle lysates, with an observed band at the predicted 46 kDa. Mouse WB performance is not shown in the supplied evidence.
Which to pick: PA1845 is the only listed option and has a WB image. The caption reports 0.5 µg/mL antibody with HeLa and rat skeletal muscle lysates; choose it based on those tested samples and the stated reactivity for your species.
Source: BosterBio ARRB2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.
References
- UniProt Consortium. UniProt entry P32121.
- Human Protein Atlas. ARRB2 tissue expression.
- PMC7449919 — target-verified WB comparison
- PMC4846526 — target-verified WB comparison
- PMC13201787 — target-verified WB comparison